Reading the tape
NASDAQ: QDEL
QuidelOrtho Corporation
Healthcare · Medical - Instruments & Supplies
Market Cap
$845.58M
52w High
$38.99
52w Low
$10.86
P/E
-0.74
Volume
1.74M
Outstanding Shares
68.08M
Price vs Fundamentals
Why The Stock Is Moving
Likely multiple compressionModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -55.15%Revenue (TTM): -1.89%FCF (TTM): 124.35%P/FCF: 55th pct
What changed
The stock fell 55.15% over the last year. Revenue declined 1.89% over the trailing twelve months. Operating margin moved from -70.46% to -33.67%. Free cash flow grew 124.35% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently -33.67%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs.
CEOBrian J. Blaser
SectorHealthcare
IndustryMedical - Instruments & Supplies
Employees6,600
IPO dateFeb 1, 1991
Valuation
Forward P/E—
EV/EBITDA-9.47
Enterprise value$4.62B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth2.23%
Gross margin46.67%▲0.96%vs FY2024
Operating margin-33.67%▲52.22%vs FY2024
ROE-58.93%▲14.29%vs FY2024
Analyst consensus
RatingBuy
Target price$17.00▲36.88%
7
Buy
6
Hold
2
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
Q2 FY26 · EPS est $0.37 · Revenue est $658.41M
View